NCT05314426
Mayo Clinic Phage Program Biobank
Enrolling by Invitation
Not specifiedAges 18+ObservationalMayo ClinicInvestigator-initiated
~100 participants
Updated 2026-06-24 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Enrollment of study participants
Measured over 5 years
+3 more outcomes measured
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Gina Suh, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
≥ 18 years of age.
Able to provide informed consent.
Individual must have a future treatment plan to receive or has historically received phage therapy.
Exclusion
Individuals , 18 years of age.
Unwilling/unable to provide informed consent.
What this trial measures
- Enrollment of study participants5 years
To recruit and enroll participants up to 100 participants who have received or will receive phage therapy treatment
- Collection of biospecimens5 years
Total number of biospecimens collected which may include blood samples and synovial fluid
- Medical record review5 years
Review the medical record of enrolled participants to ascertain any new health outcomes.
- Increase treatment options and level of care for patients with bacterial infections5 years
Total number of collaborations with clinical investigators and researchers at both Mayo Clinic and across the globe.